| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $17.8M | +150.8% |
| SG&A Expense | $7.3M | -6.4% |
| Operating Income | -$25.1M | -63.0% |
| Income Tax | $0 | — |
| Net Income | -$24.0M | -61.5% |
| EPS (Basic) | -$1.50 | -61.3% |
| EPS (Diluted) | -$1.50 | -61.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.4M | -59.3% |
| Current Assets | $16.0M | -57.6% |
| Total Assets | $16.1M | -57.7% |
| Current Liabilities | $4.2M | +30.7% |
| Total Liabilities | $4.2M | +30.7% |
| Stockholders' Equity | $11.9M | -65.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.0M | -55.3% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | -$21.0M | -54.9% |